ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 117 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2019. The put-call ratio across all filers is 0.32 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $9,105,000 | -25.6% | 6,950,000 | 0.0% | 0.17% | -20.2% |
| Q4 2021 | $12,232,000 | -18.9% | 6,950,000 | 0.0% | 0.21% | -12.2% |
| Q3 2021 | $15,082,000 | -38.0% | 6,950,000 | 0.0% | 0.24% | -44.0% |
| Q2 2021 | $24,325,000 | -69.2% | 6,950,000 | -13.1% | 0.42% | -68.9% |
| Q1 2021 | $78,880,000 | -9.0% | 8,000,000 | 0.0% | 1.36% | -8.8% |
| Q4 2020 | $86,720,000 | +5.2% | 8,000,000 | 0.0% | 1.49% | +27.5% |
| Q3 2020 | $82,400,000 | -48.0% | 8,000,000 | +5.5% | 1.17% | -62.6% |
| Q2 2020 | $158,375,000 | +126.7% | 7,585,000 | +6.1% | 3.13% | +32.8% |
| Q1 2020 | $69,856,000 | +15.5% | 7,150,000 | +36.2% | 2.36% | +32.8% |
| Q4 2019 | $60,480,000 | +161.1% | 5,250,000 | +23.5% | 1.78% | +83.9% |
| Q3 2019 | $23,163,000 | -44.3% | 4,250,000 | +21.4% | 0.97% | -32.9% |
| Q2 2019 | $41,615,000 | – | 3,500,000 | – | 1.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 4,112,355 | $40,178,000 | 34.81% |
| Versant Venture Management, LLC | 7,068,233 | $69,056,636,000 | 18.94% |
| ACUTA CAPITAL PARTNERS, LLC | 1,704,500 | $16,653,000 | 8.07% |
| Soleus Capital Management, L.P. | 313,900 | $3,067,000 | 3.57% |
| Ghost Tree Capital, LLC | 1,305,500 | $12,755,000 | 3.38% |
| SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) | 480,000 | $4,690,000 | 2.97% |
| RTW INVESTMENTS, LP | 6,631,627 | $64,791,000 | 2.79% |
| VR Adviser, LLC | 994,381 | $9,715,000 | 2.63% |
| Avoro Capital Advisors LLC | 7,150,000 | $69,856,000 | 2.36% |
| RA Capital Management | 7,272,714 | $71,054,000 | 2.24% |